Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations

Drug and Alcohol Dependence

Volumn 126, Issue 1-2, 2012, Pages 87-94

  McFadden, Lisa M ^a   Hunt, Madison M ^a   Vieira Brock, Paula L ^a   Muehle, Janice ^a   Nielsen, Shannon M ^a   Allen, Scott C ^a   Hanson, Glen R ^a   Fleckenstein, Annette E ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Hippocampus; Methamphetamine; Self administration; Serotonin

Indexed keywords

METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER; SODIUM CHLORIDE;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SYNAPTOSOME;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES;

RATTUS;

EID: 84867852948     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.04.020     Document Type: Article

References (43)

1. Axt K.J., Molliver M.E. Immunocytochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 1991, 9:302-313.
2. Barr A.M., Panenka W.J., MacEwan G.W., Thornton A.E., Lang D.J., Honer W.G., Lecomte T. The need for speed: an update on methamphetamine addiction. J. Psychiatry Neurosci. 2006, 31:301-313.
3. Belcher A.M., Feinstein E.M., O'Dell S.J., Marshall J.F. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsychopharmacology 2008, 33:1453-1463.
4. Bowyer J.F., Robinson B., Ali S., Schmued L.C. Neurotoxic-related changes in tyrosine hydroxylase, microglia, myelin, and the blood-brain barrier in the caudate-putamen from acute methamphetamine exposure. Synapse 2008, 62:193-204.
5. Brennan K.A., Colussi-Mas J., Carati C., Lea R.A., Fitzmaurice P.S., Schenk S. Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat. Brain Res 2010, 131:137-146.
6. Cadet J.L., Krasnova I.N. Molecular bases of methamphetamine-induced neurodegeneration. Int. Rev. Neurobiol. 2009, 88:101-119.
7. Cadet J.L., Krasnova I.N., Ladenheim B., Cai N.S., McCoy M.T., Atianjoh F.E. Methamphetamine preconditioning: differential protective effects on monoaminergic systems in the rat brain. Neurotox. Res. 2009, 15:252-259.
8. Chang L., Alicata D., Ernst T., Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl. 1):16-32.
9. Cornish J.L., Clemens K.J., Thompson M.R., Callaghan P.D., Dawson B., McGregor I.S. High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. J. Psychopharmacol. 2008, 22:100-110.
10. Danaceau J.P., Deering C.E., Day J.E., Smeal S.J., Johnson-Davis K.L., Fleckenstein A.E., Wilkins D.G. Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur. J. Pharmacol. 2007, 559:46-54.
11. Farfel G.M., Seiden L.S. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 1995, 272:868-875.
12. Fleckenstein A.E., Wilkins D.G., Gibb J.W., Hanson G.R. Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J. Pharmacol. Exp. Ther. 1997, 283:281-285.
13. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 2007, 47:681-698.
14. Frankel P.S., Hoonakker A.J., Hanson G.R. Differential response of neurotensin to methamphetamine self-administration. Ann. N. Y. Acad. Sci. 2008, 1139:112-117.
15. Frankel P.S., Hoonakker A.J., Alburges M.E., McDougall J.W., McFadden L.M., Fleckenstein A.E., Hanson G.R. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia. J. Pharmacol. Exp. Ther. 2011, 336:809-815.
16. Graham D.L., Noailles P.A., Cadet J.L. Differential neurochemical consequences of an escalating dose-binge regimen followed by single-day multiple-dose methamphetamine challenges. J. Neurochem. 2008, 105:1873-1885.
17. Hadlock G.C., Webb K.M., McFadden L.M., Chu P.W., Ellis J.D., Allen S.C., Andrenyak D.M., Vieira-Brock P.L., German C.L., Conrad K.M., Hoonakker A.J., Gibb J.W., Wilkins D.G., Hanson G.R., Fleckenstein A.E. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther. 2011, 339:530-536.
18. Hart C.L., Marvin C.B., Silver R., Smith E.E. Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology 2012, 37:586-608.
19. Haughey H.M., Fleckenstein A.E., Metzger R.R., Hanson G.R. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia. J. Neurochem. 2000, 75:1608-1617.
20. Herring N.R., Gudelsky G.A., Vorhees C.V., Williams M.T. (+)-Methamphetamine-induced monoamine reductions and impaired egocentric learning in adrenalectomized rats is independent of hyperthermia. Synapse 2010, 64:773-785.
21. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 1980, 214:257-262.
22. Johnson-Davis K.L., Fleckenstein A.E., Wilkins D.G. The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur. J. Pharmacol. 2003, 482:151-154.
23. Kalasinsky K.S., Bosy T.Z., Schmunk G.A., Reiber G., Anthony R.M., Furukawa Y., Guttman M., Kish S.J. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic Sci. Int. 2001, 116:163-169.
24. Kim Y.T., Lee J.J., Song H.J., Kim J.H., Kwon D.H., Kim M.N., Yoo D.S., Lee H.J., Kim H.J., Chang Y. Alterations in cortical activity of male methamphetamine abusers performing an empathy task: fMRI study. Hum. Psychopharmacol. 2010, 25:63-70.
25. Kish S.J., Fitzmaurice P.S., Boileau I., Schmunk G.A., Ang L.C., Furukawa Y., Chang L.J., Wickham D.J., Sherwin A., Tong J. Brain serotonin transporter in human methamphetamine users. Psychopharmacology (Berl.) 2009, 202:649-661.
26. Kiyatkin E.A., Sharma H.S. Acute methamphetamine intoxication brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. Int. Rev. Neurobiol. 2009, 88:65-100.
27. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology. 2010, 35:217-238.
28. McFadden L.M., Hoonakker A.J., Vieira-Brock P.L., Stout K.A., Sawada N.M., Ellis J.D., Allen S.C., Walters E.T., Nielsen S.M., Gibb J.W., Alburges M.E., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration. Synapse 2011, 65:771-777.
29. McFadden L.M., Hadlock G.C., Allen S.C., Vieira-Brock P.L., Stout K.A., Ellis J.D., Hoonakker A.J., Anderyak D.M., Neilson S.M., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure. J. Pharmacol. Exp. Ther. 2012, 340:295-303.
30. O'Neil M.L., Kuczenski R., Segal D.S., Cho A.K., Lacan G., Melega W.P. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge. Synapse 2006, 60:465-473.
31. Orikabe L., Yamasue H., Inoue H., Takayanagi Y., Mozue Y., Sudo Y., Ishii T., Itokawa M., Suzuki M., Kurachi M., Okazaki Y., Kasai K. Reduced amygdala and hippocampal volumes in patients with methamphetamine psychosis. Schizophr. Res. 2011, 132:183-189.
32. Reichel C.M., Ramsey L.A., Schwendt M., McGinty J.F., See R.E. Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology 2012, 62:1119-1126.
33. Richards J.B., Baggott M.J., Sabol K.E., Seiden L.S. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Res. 1993, 627:254-260.
34. Ricoy U.M., Martinez J.L. Local hippocampal methamphetamine-induced reinforcement. Front. Behav. Neurosci. 2009, 3:47.
35. Saldaña S.N., Barker E.L. Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake. Neurosci. Lett. 2004, 354:209-212.
36. Schröder N., O'Dell S.J., Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 2003, 49:89-96.
37. Sekine Y., Ouchi Y., Takei N., Yoshikawa E., Nakamura K., Futatsubashi M., Okada H., Minabe Y., Suzuki K., Iwata Y., Tsuchiya K.J., Tsukada H., Iyo M., Mori N. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch. Gen. Psychiatry 2006, 63:90-100.
38. Sharma H.S., Sjoquist P.O., Ali S.F. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidate compound H-290/51. Curr. Pharm. Des. 2007, 13:1903-1923.
39. Stephans S., Yamamoto B. Methamphetamines pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity. Neuroscience 1996, 72:593-600.
40. Stone D.M., Johnson M., Hanson G.R., Gibb J.W. Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur. J. Pharmacol. 1989, 172:93-97.
41. Tata D.A., Yamamoto B.K. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction 2007, 102(Suppl. 1):49-60.
42. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., London E.D. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 2004, 24:6028-6036.
43. Yamamoto B.K., Moszczynska A., Gudelsky G.A. Amphetamine toxicities: classical and emerging mechanisms. Ann. N. Y. Acad. Sci. 2010, 1187:101-121.